[en] OBJECTIVE: To examine the factors associated with liver steatosis in severely obese subjects and to test the potential reversibility of fatty liver after weight loss. DESIGN: Retrospective clinical study. SUBJECT: 528 obese patients before bariatric surgery and 69 obese subjects of the initial cohort evaluated before and 27+/-15 months after gastroplasty. MEASUREMENTS: Fatty deposition (scored as mild, moderate or severe) and inflammatory changes were evaluated in liver biopsies; clinical (body mass index (BMI), age, gender, duration of obesity) and biological (glucose, triglycerides, liver enzymes) parameters were related to histological findings. RESULTS: 74% of the 528 biopsies showed fatty change, estimated as mild in 41% of cases, moderate in 32% and severe in 27%. The prevalence of steatosis was significantly higher in men than in women (91% vs 70%, P = 0.001) and in patients with impaired glucose tolerance or type 2 diabetes compared with nondiabetics (89% vs 69% P = 0.001). The severity of the steatosis was associated with BMI (P = 0.002) but not with the duration of obesity or the age of the patient. When compared with patients without fatty change, those with liver steatosis had significantly higher fasting plasma glucose (5.5 mmol/l vs 5.1 mmol/l, P = 0.007) and triglycerides (1.8 mmol/l vs 1.3 mmol/l, P = 0.002). Mean serum liver enzyme activities (alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl-transpeptidase (gammaGT) were significantly (P < 0.001) increased in patients with fatty change but remained within laboratory reference values. In the 69 patients who have been evaluated after a marked weight reduction (-32+/-19kg), 45% of the biopsies were considered as normal (vs 13% before, P < 0.001) while pure fatty change was still observed in 38% of the patients (vs 83% before, P = 0.001). However, the severity of the steatosis was significantly (P < 0.001) reduced (mild: 62% vs 21%; moderate: 23% vs 37%; severe: 15% vs 42%). In addition, a significant increase of hepatitis was observed in 26% of the biopsies (vs 14% before, P < 0.05). CONCLUSIONS: Liver steatosis in obese subjects is associated with men, diabetic status, BMI, higher fasting glucose and hypertriglyceridaemia. Postgastroplasty weight loss reduces liver steatosis, but seems to increase the incidence of inflammatory lobular hepatitis.
Disciplines :
Surgery Endocrinology, metabolism & nutrition
Author, co-author :
Luyckx, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Desaive, Claude ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Thiry, Albert ; Université de Liège - ULiège > Anatomie pathologique
Dewe, W.
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Gielen, Jean-Louis ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie maxillo-faciale et plastique
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
English
Title :
Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.
Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.
Alder M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67: 811-816.
Kern WH, Heger AH, Payne JH. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 1973; 96: 342-346.
Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990; 47: 208-214.
Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes 1995; 19 (Suppl 3): S27-S36.
Andersen T, Gluud C. Liver morphology in morbid obesity: a literature survey. Int J Obes 1984; 8: 97-106.
Laws H. Standardized gastroplasty orifice. Am J Surg 1981; 141: 393-394.
Kuzmak L. Gastric banding in surgery for the morbidly obese patient. In: Dietel M. (ed). Surgery for the morbidly obese patient. 1989; Lea and Febiger: Philadelphia, Chap 12.
Spiegel MR. Theory and problems of probability and statistics 1975; McGraw-Hill: New York.
SAS Institute Inc: SAS/STAT User's Guide, Version 6.11 (4th edn). 1995; SAS Institute Inc, Cary, N C.
New York Metropolitan Life Insurance Co. Measurement of overweight. Statist Bull Metrop Life Insur Co 1984; 65: 20 23.
Teli MR, James OF, Burt AD. The natural history of non-alcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-1719.
Alder M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67: 811-816.
Letteron P, Fromenty B, Terris B. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatology 1996; 24: 200-208.
Manes JL, Taylor HB, Starkloff GB. Relationship between hepatic morphology and clinical and biological findings in morbidly obese patients. J Clin Pathol 1973; 26: 776-783.
Silverman J, O'Brien K, Long S, Leggett N, Khazanie P, Pories W, Norris T, Caro J. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990; 85: 1349-1355.
Sims E, Danforth E, Horton ES. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973; 29: 457-487.
Scheen AJ, Paquot N, Letiexhe M, Paolisso G, Castillo MJ, Lefèbvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT, and clamp studies. Int J Obes 1995; 19 (Suppl 3): S14-S20.
Andersen T, Christoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study. Int J Obes 1984; 8: 107-115.
Braillon A, Capron JP, Hervé MA, Degott C, Quenum C. Liver in obesity. Cut 1985; 26: 133-139.
Silverman E, Sapala J, Appelman H. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathology 1995; 104: 23-31.
Galambos JT, Wills CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 1978; 74: 1191-1195.
Letiexhe MR, Scheen AJ, Gérard PL, Desaive C. Lefèbvre PJ. Post-gastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab 1995; 80: 393-399.
Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatology 1991; 12: 224-229.